哎呀哎呀在线观看视频|狼狼鲁色在线视频播放|天天躁日日躁狠狠躁欧美老妇|波斯女人1977满天星|九阳真经未满十八岁能学吗|被老外做的都肿了|7tv影院

Your Good Partner in Biology Research

  1. Home
  2. 抗體
  3. 多克隆抗體
  4. SETBP1 Antibody, HRP conjugated

SETBP1 Antibody, HRP conjugated

  • 中文名稱：
    SETBP1兔多克隆抗體, HRP偶聯
  • 貨號：
    CSB-PA896935LB01HU
  • 規格：
    ￥880
  • 其他：

產品詳情

  • 產品名稱：
    Rabbit anti-Homo sapiens (Human) SETBP1 Polyclonal antibody
  • Uniprot No.：
  • 基因名：
  • 別名：
    SEB antibody; SET binding protein 1 antibody; SET-binding protein antibody; SETBP 1 antibody; SETBP_HUMAN antibody; Setbp1 antibody
  • 宿主：
    Rabbit
  • 反應種屬：
    Human
  • 免疫原：
    Recombinant Human SET-binding protein (1-242AA)
  • 免疫原種屬：
    Homo sapiens (Human)
  • 標記方式：
    HRP
  • 克隆類型：
    Polyclonal
  • 抗體亞型：
    IgG
  • 純化方式：
    >95%, Protein G purified
  • 濃度：
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液：
    Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
  • 產品提供形式：
    Liquid
  • 應用范圍：
    ELISA
  • Protocols：
  • 儲存條件：
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期：
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途：
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

  • 基因功能參考文獻：
    1. Data indicate a SET binding protein 1 (SETBP1) function that directly affects gene transcription. PMID: 29875417
    2. SETBP1 mutations were a rare molecular event in acute myeloid leukemia and myelodysplastic syndrome patients PMID: 29549983
    3. we report here for the first time changes in the allele frequencies of CSF3R-T618I and SETBP1-G870S with response to ruxolitnib as well as insights into the clonal evolution of CNL under selective pressure from ruxolitinib. PMID: 28209656
    4. we report the results of a screening for mutations in SETBP1 and JAK3 of a cohort of seventy Italian patients with juvenile myelomonocytic leukemia, identifying 11.4% of them harboring secondary mutations in these two genes and discovering two new mutations in the SKI domain of SETBP1 PMID: 26980750
    5. Patients with SETBP1 hotspot mutations suffered from aggressive disease with rapid evolution and inferior overall survival. Patients with SETBP1 non-hotspot mutations had less aggressive disease and a more favorable prognosis. PMID: 28913558
    6. SETBP1 mutation is associated with chronic myelomonocytic leukemia. PMID: 28209919
    7. Somatic c.2608G > A (p.Gly870Ser) in the SETBP1 gene identified in a patient with Fnaconi anemia. PMID: 28419882
    8. Current evidence shows that SETBP1 mutation is associated with a poor prognosis in patients with MDS and CMML, but not in patients with chronic neutrophilic leukemia. PMID: 28158286
    9. SETBP1 is a major oncogene in myeloid neoplasms, which cooperates with various genetic events and causes distinct phenotypes of myelodysplastic/myeloproliferative neoplasms and secondary acute myeloid leukemia. PMID: 28447248
    10. Results indicate a genotype-phenotype correlation in germline SET binding protein 1 (SETBP1) mutations spanning a molecular, cellular and clinical phenotype. PMID: 28346496
    11. AML with RUNX1/RUNX1T1 rearrangement displayed c.2903C>T alteration in the mutational hotspot of SETBP1. PMID: 25553291
    12. Data describe a new recurrent chromosome translocation, t(12;18)(q14-q15;q12-21), in lipomas and osteochondrolipoma resulting in HMGA2-SETBP1 fusion which suggest a close developmental relationship between the two tumor types. PMID: 26202160
    13. we described a patient not fulfilling the clinical criteria and showing mutation in SETBP1, we suggest that the facial gestalt associated with neurological involvement would be sufficient to indicate molecular analysis of this particular gene. PMID: 25663181
    14. Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations. PMID: 25716545
    15. The SETBP1 and ASXL1 mutations have pathogenetic roles in CSF3R-mutated chronic neutrophilic leukemia. PMID: 25850813
    16. SETBP1 mutation might not be involved in the leukemogenisis of acute lymphoblastic leukemia PMID: 24359242
    17. SETBP1 mutations are critical drivers of ASXL1-mutated myelodysplastic syndrome. PMID: 25306901
    18. mutation analysis of CSF3R, SETBP1 and CALR should be included in the diagnostic criteria for chronic neutrophilic leukemia PMID: 25316523
    19. Low frequency of SETBP1 mutations have been found in 106 patients with therapy-related myeloid neoplasms. PMID: 24907359
    20. Mutations in SETBP1 are associated with juvenile myelomonocytic leukemia. PMID: 25395418
    21. In univariate analysis, survival was adversely affected by ASXL1 (nonsense and frameshift) but not SETBP1 mutations for chronic myelomonocytic leukemia. PMID: 24695057
    22. SETBP1 mutations were found in 4.8% of patients with JMML in this study. PMID: 24117422
    23. SETBP1 and SRSF2 are the most common somatic genetic abnormalities in patients with myeloid neoplasms carrying isochrmosome 17(q10), and may be important drivers of disease pathogenesis. PMID: 24796269
    24. The SETBP1 mutation is associated with poor prognosis in MDS. The mutation can be acquired during the clinical course suggesting it may play a role in disease progression. PMID: 24127063
    25. The data suggest that SETBP1 mutations may play a role in myelodysplastic syndromes and chronic myelomonocytic leukaemia disease progression. PMID: 23889083
    26. SETBP1 mutation is associated with myelodysplastic syndromes and acute myeloid leukemia. PMID: 23648668
    27. SETBP1 mutations are associated with chronic myelomonocytic leukemia. PMID: 23558523
    28. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. PMID: 23604229
    29. SETBP1 mutations represent an important novel molecular marker, which is highly associated with aCML, the MDS/MPN overlap category and a dysplastic phenotype. PMID: 23628959
    30. Mutations of SETBP1 and JAK3 were common recurrent secondary events presumed to be involved in tumor progression and were associated with poor clinical outcomes. PMID: 23832011
    31. Somatic mutations of SETBP1 seem to cause gain of function, are associated with myeloid leukemic transformation and convey poor prognosis in myelodysplastic syndromes (MDS) and CMML. PMID: 23832012
    32. In MDS and sAML, the rare mutations in SETBP1 might be associated with distinct cytogenetic aberrations involving chromosomes 3 and 7. PMID: 23443343
    33. mutated SETBP1 represents a newly discovered oncogene present in Atypical chronic myeloid leukemia (aCML) and closely related diseases. PMID: 23222956
    34. We describe a patient with a 18q12.3 microdeletion that causes the disruption of SETBP1 resulting in mild mental retardation and expressive speech impairment with striking discrepancy between expressive and receptive language skills. PMID: 22333924
    35. study of 2 unrelated Thai patients with clinical manifestations fulfilling criteria of Schinzel-Giedion syndrome; demonstrate SETBP1 is gene responsible for SGS in Thai patients confirming previous report of this gene associated with SGS in Caucasians PMID: 21371013
    36. Reduced expression by SETBP1 haploinsufficiency causes developmental and expressive language delay indicating a phenotype distinct from Schinzel-Giedion syndrome. PMID: 21037274
    37. We sequenced the exomes of four affected individuals (cases) and found heterozygous de novo variants in SETBP1 in all four PMID: 20436468
    38. Correction of X-linked chronic granulomatous disease by gene therapy was augmented by insertional activation of SETBP1. PMID: 16582916

    顯示更多

    收起更多

  • 相關疾病：
    Schinzel-Giedion midface retraction syndrome (SGMFS); Myelodysplastic syndrome (MDS); Mental retardation, autosomal dominant 29 (MRD29); Leukemia, acute myelogenous (AML); Leukemia, chronic myeloid, atypical (ACML); Leukemia, juvenile myelomonocytic (JMML)
  • 亞細胞定位：
    Nucleus.
  • 組織特異性：
    Expressed in numerous tissues. Expressed at low levels in myeloid and monocytic cells as well as in CD34+ cells; expression levels are higher in myeloid malignancies.
  • 數據庫鏈接：

    HGNC: 15573

    OMIM: 269150

    KEGG: hsa:26040

    STRING: 9606.ENSP00000282030

    UniGene: Hs.435458



×
生命科學計算平臺